{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T20:22:08Z","timestamp":1789590128234,"version":"build-2803163510"},"reference-count":34,"publisher":"Wiley","issue":"5","license":[{"start":{"date-parts":[[2007,8,23]],"date-time":"2007-08-23T00:00:00Z","timestamp":1187827200000},"content-version":"vor","delay-in-days":5592,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Acta Psychiatr Scand"],"published-print":{"date-parts":[[1992,5]]},"abstract":"<jats:p>A decreased incidence of cancer of the prostate has been demonstrated in a cohort of 6168 chronic schizophrenic patients followed up from 1957 to 1984. A case\u2010control study was performed based on this cohort to determine the possible influence of neuroleptic treatment and other factors on the risk of developing prostate cancer. Thirty\u2010eight male schizophrenic patients who had developed prostate cancer during the observation period were compared with 76 age\u2010 and sex\u2010matched controls from the same cohort. The only significant association was that of a reduced risk of prostate cancer among those who had been treated with a cumulative dose of high\u2010dose phenothiazines (primarily chlorpromazine) of 15 g or more. These patients had been treated with an average daily dose of 145 mg chlorpromazine for an average of 12.5 years. No other significant risk factors were identified.<\/jats:p>","DOI":"10.1111\/j.1600-0447.1992.tb10325.x","type":"journal-article","created":{"date-parts":[[2007,8,23]],"date-time":"2007-08-23T12:21:30Z","timestamp":1187871690000},"page":"390-393","source":"Crossref","is-referenced-by-count":61,"title":["Neuroleptic medication and reduced risk of prostate cancer in schizophrenic patients"],"prefix":"10.1111","volume":"85","author":[{"given":"P. B.","family":"Mortensen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2007,8,23]]},"reference":[{"key":"e_1_2_1_2_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1464-410X.1987.tb04862.x"},{"key":"e_1_2_1_3_2","first-page":"43","volume-title":"Dietary fat and cancer","author":"Rose DP.","year":"1986"},{"key":"e_1_2_1_4_2","first-page":"173","article-title":"Studies on the epidemiology of prostatic cancer: expanded sampling","volume":"61","author":"Rotkin JD.","year":"1977","journal-title":"Cancer Treat Rep"},{"key":"e_1_2_1_5_2","first-page":"181","article-title":"Epidemiologic study of prostatic cancer: preliminary report","volume":"61","author":"Schuman LM","year":"1977","journal-title":"Cancer Treat Rep"},{"key":"e_1_2_1_6_2","first-page":"149","article-title":"Epidemiology of prostate cancer with special reference to the role of diet","volume":"53","author":"Hirayama T.","year":"1979","journal-title":"Natl Cancer Inst Monogr"},{"key":"e_1_2_1_7_2","first-page":"687","article-title":"Diet in the epidemiology of carcinoma of the prostate gland","volume":"70","author":"Graham S","year":"1983","journal-title":"J Natl Cancer Inst"},{"key":"e_1_2_1_8_2","doi-asserted-by":"publisher","DOI":"10.1016\/0021-9681(63)90091-2"},{"key":"e_1_2_1_9_2","doi-asserted-by":"publisher","DOI":"10.4159\/harvard.9780674424593"},{"key":"e_1_2_1_10_2","first-page":"229","volume-title":"Psychiatric case registers in public health. A worldwide inventory 1960\u20131985","author":"Dupont A","year":"1986"},{"key":"e_1_2_1_11_2","doi-asserted-by":"publisher","DOI":"10.1136\/jech.43.1.43"},{"key":"e_1_2_1_12_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0447.1987.tb02839.x"},{"key":"e_1_2_1_13_2","doi-asserted-by":"publisher","DOI":"10.1093\/biomet\/73.1.1"},{"key":"e_1_2_1_14_2","first-page":"173","article-title":"Ambidirectional studies \u2013 an extension of longitudinal studies in psychiatry","volume":"2","author":"Mortensen PB.","year":"1988","journal-title":"Psychiatr Dev"},{"key":"e_1_2_1_15_2","doi-asserted-by":"publisher","DOI":"10.1093\/oxfordjournals.aje.a114442"},{"key":"e_1_2_1_16_2","volume-title":"Statistical methods in cancer research. The analysis of case\u2010control studies","author":"Breslow NE","year":"1980"},{"key":"e_1_2_1_17_2","first-page":"405","article-title":"\u00dcber die Kombinationsbehandlung mit entkoppelnden Substanzen bei malignen Tumoren","volume":"17","author":"L\u00fchrs W","year":"1962","journal-title":"Krebsarzt"},{"key":"e_1_2_1_18_2","doi-asserted-by":"publisher","DOI":"10.3109\/08039486109167943"},{"key":"e_1_2_1_19_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(72)92955-8"},{"key":"e_1_2_1_20_2","first-page":"186","article-title":"G\u00fcnstige Verl\u00e4ufe bei Karzinompatienten unter zus\u00e4tzlicher Behandlung mit Phenothiazinderivaten","volume":"70","author":"Eicke W\u2010J.","year":"1975","journal-title":"Med Klin"},{"key":"e_1_2_1_21_2","first-page":"1111","article-title":"Effect of fluphenazine HC1 on R3230AC mammary carcinoma and mammary glands of the rat","volume":"31","author":"Hilf R","year":"1971","journal-title":"Cancer Res"},{"key":"e_1_2_1_22_2","doi-asserted-by":"publisher","DOI":"10.1248\/cpb.17.848"},{"key":"e_1_2_1_23_2","first-page":"529","article-title":"Relationship between antitumor activity and chemical structure in psychotropic agents","volume":"61","author":"Kanzawa F","year":"1970","journal-title":"Gann"},{"key":"e_1_2_1_24_2","first-page":"225","article-title":"Antitumor activity of haloacetylphenothiazines against ascites sarcoma\u2010180","volume":"63","author":"Kanzawa F","year":"1972","journal-title":"Gann"},{"key":"e_1_2_1_25_2","first-page":"155","article-title":"Phenothiazine inhibition of intestinal and urinary bladder tumors induced in rats by braken fern","volume":"47","author":"Pamukcu AM","year":"1971","journal-title":"J Natl Cancer Inst"},{"key":"e_1_2_1_26_2","first-page":"45","article-title":"Psychotropic drugs as potential antitumor agents: a selective screening study","volume":"62","author":"Driscoll JS","year":"1978","journal-title":"Cancer Treat Rep"},{"key":"e_1_2_1_27_2","doi-asserted-by":"publisher","DOI":"10.1177\/030089168507100608"},{"key":"e_1_2_1_28_2","first-page":"839","article-title":"Circumvention of multiple\u2010drug resistance in human cancer cells by thioridazine, trifluoperazine, and chlorpromazine","volume":"76","author":"Akiyama S","year":"1986","journal-title":"J Natl Cancer Inst"},{"key":"e_1_2_1_29_2","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1200\/JCO.1988.6.5.880","article-title":"Clinical modulation of doxorubicin resistance by the calmodulininhibitor, trifluoperazine: a phase I\/II trial","volume":"6","author":"Miller RL","year":"1988","journal-title":"J Clin Oncol"},{"key":"e_1_2_1_30_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF00435836"},{"key":"e_1_2_1_31_2","doi-asserted-by":"publisher","DOI":"10.1016\/0163-8343(87)90062-4"},{"key":"e_1_2_1_32_2","first-page":"192","article-title":"Cancer of the prostate: endocrine factors","volume":"9","author":"Griffiths K","year":"1987","journal-title":"Oxf Rev Reprod Biol"},{"key":"e_1_2_1_33_2","first-page":"337","volume-title":"Handbook of schizophrenia, Vol 2, Neurochemistry and neuropharmacology of schizophrenia","author":"Powchik P","year":"1987"},{"key":"e_1_2_1_34_2","first-page":"241","volume-title":"Kostunders\u00f8gelser i institutioner","author":"Uhl E.","year":"1967"},{"key":"e_1_2_1_35_2","first-page":"387","volume-title":"The pharmacological basis of therapeutics","author":"Baldessarini RJ.","year":"1985"}],"container-title":["Acta Psychiatrica Scandinavica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1600-0447.1992.tb10325.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1600-0447.1992.tb10325.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,23]],"date-time":"2023-10-23T13:47:35Z","timestamp":1698068855000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1600-0447.1992.tb10325.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1992,5]]},"references-count":34,"journal-issue":{"issue":"5","published-print":{"date-parts":[[1992,5]]}},"alternative-id":["10.1111\/j.1600-0447.1992.tb10325.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1600-0447.1992.tb10325.x","archive":["Portico"],"relation":{},"ISSN":["0001-690X","1600-0447"],"issn-type":[{"value":"0001-690X","type":"print"},{"value":"1600-0447","type":"electronic"}],"subject":[],"published":{"date-parts":[[1992,5]]}}}